Craneware (LON:CRW) Shares Climb 2.2% – Here’s Why

Craneware plc (LON:CRW) shot up 2.2% on Tuesday. The stock traded as high as GBX 1,056 and last traded at GBX 1,030. Approximately 862,850 shares traded hands during trading, an increase of 31% from the average session volume of 657,188 shares. The stock had previously closed at GBX 1,008.

Analyst Ratings Changes

Separately, Berenberg Bank decreased their target price on Craneware from GBX 2,600 to GBX 1,600 and set a “buy” rating for the company in a research note on Monday, September 21st. Three research analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, Craneware currently has an average rating of “Buy” and an average price target of GBX 1,673.33.

Craneware Stock Performance

The firm’s 50 day moving average price is GBX 1,134.99 and its 200-day moving average price is GBX 1,340.16. The firm has a market cap of £354.17 million, a price-to-earnings ratio of 18.39 and a beta of 0.28. The company has a debt-to-equity ratio of 14.60, a current ratio of 0.83 and a quick ratio of 1.00.

Insider Buying and Selling at Craneware

In related news, insider Susan Nelson purchased 1,408 shares of the firm’s stock in a transaction on Tuesday, September 22nd. The shares were bought at an average cost of GBX 1,054 per share, for a total transaction of £14,840.32. Also, insider Craig Preston sold 14,656 shares of the business’s stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of GBX 1,035, for a total transaction of £151,689.60. 10.37% of the stock is owned by corporate insiders.

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.